Autoimmune liver diseases and SARS-CoV-2

doi:10.3748/wjg.v29.i12.1838

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 12

This Article

(174)

(194)

(0)

(8)

(6938)

(19)

Peer-Review Report of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Minireviews

World J Gastroenterol. Mar 28, 2023; 29(12): 1838-1851
Published online Mar 28, 2023. doi: 10.3748/wjg.v29.i12.1838

Table 3 Cases of autoimmune hepatitis-like syndromes after coronavirus disease 2019 vaccine: Diagnostics, treatment, and clinical outcomes

Diagnostics
Peak laboratory values (mean ± SD)
AST (IU/l)	936 ± 523
ALT (IU/l)	1060 ± 567
GGT (IU/l)	312 ± 220
ALP (IU/l)	209 ± 95
Bilirubin (mg/dL)	9.8 ± 8.5
IgG (g/L)	21.7 ± 6.7
Antibodies, n (%)
ANA	33 (83)
ASMA	7 (18)
SLA/LP	2 (5)
AMA	5 (13)
Others (ANCA, DS-DNA)	3 (8)
Liver biopsy
Performed	39
Not performed	1
Morphologic characteristics, n (%)
Interface hepatitis	31 (78)
Lymphoplasmacellular infiltrates	36 (90)
Rosette formation	5 (13)
*Treatment*
First agent
Budesonide	1
Prednisone	15
Prednisolone	17
Methylprednisolone	3
Hydrocortisone	1
Steroids	3
No treatment	2
Second agent
Azathioprine	8
Prednisolone	2
Clinical outcomes
Time to the first improvement, days (mean ± SD)	4.6 ± 2.9
Time to resolution, days (mean ± SD)	44.6 ± 37
Alive	37
Dead	3

AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; GGT: Gamma-glutamyl transferase; ALP: Alkaline phosphatase; IgG: Immunoglobulin G; ANA: Antinuclear antibody; ASMA: Anti-smooth muscle antibody; SLA/LP: Anti-soluble liver antigen/liver-pancreas; AMA: Anti-mitochondrial antibodies; ANCA: Anti-neutrophil cytoplasmic antibodies; Ds-DNA: Anti-double stranded DNA.

Full Size Table

Citation: Sgamato C, Rocco A, Compare D, Minieri S, Marchitto SA, Maurea S, Nardone G. Autoimmune liver diseases and SARS-CoV-2. World J Gastroenterol 2023; 29(12): 1838-1851
URL: https://www.wjgnet.com/1007-9327/full/v29/i12/1838.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i12.1838

Sgamato C, Rocco A, Compare D, Minieri S, Marchitto SA, Maurea S, Nardone G. Autoimmune liver diseases and SARS-CoV-2. World J Gastroenterol 2023; 29(12): 1838-1851 [PMID: 37032727 DOI: 10.3748/wjg.v29.i12.1838]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.